Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02797600 · ClinicalTrials.gov registry record

Community Awareness, Resources and Education (CARE II) Project: Project 1

A clinical trial, sponsored by Ohio State University Comprehensive Cancer Center.

Completed
Registry status
285
Enrollment target

NCT02797600: Completed study, sponsored by Ohio State University Comprehensive Cancer Center.

NCT02797600 is a clinical trial that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 285 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02797600 has completed, sponsored by Ohio State University Comprehensive Cancer Center.

COMPLETED
Registry status
285 participants
Enrollment target

Study Summary

The study hypothesis is that the increased incidence of cervical cancer observed in Appalachian women over their non-Appalachian counterparts is due in part to inherited and somatic alterations of key components of the Transforming Growth Factor β (TGFβ) signaling pathway.

Primary Outcome

The number of participants with genetic variations in TGFβ ligand and receptor genes and other cancer-associated genes with known single nucleotide polymorphisms as determined by direct sequencing and SNP PCR analyses

Interventions

  • BEHAVIORAL Questionnaires
  • OTHER Biological Samples

Trial Details

FieldValue
Enrollment Target 285 participants
Start Date 2011-06
Est. Completion 2015-04

What the finished NCT02797600 record still lists

NCT02797600 is an observational study that tracks outcomes without assigning an intervention. The registered 285 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 2 interventions - of which Questionnaires is the first listed.

NCT02797600 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02797600 about?

NCT02797600 is a clinical study titled "Community Awareness, Resources and Education (CARE II) Project: Project 1". The study hypothesis is that the increased incidence of cervical cancer observed in Appalachian women over their non-Appalachian counterparts is due in part to inherited and somatic alterations of key components of the Transforming Growth Factor β (TGFβ) signaling pathway.

What is the current status of trial NCT02797600?

This trial is currently completed. The enrollment target is 285 participants. The study started on 2011-06. Estimated completion is 2015-04.

What interventions are being tested in trial NCT02797600?

The interventions under investigation include: Questionnaires (BEHAVIORAL), Biological Samples (OTHER).

Who is sponsoring clinical trial NCT02797600?

This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03412877 · 285 participants · Phase 2

    Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer

  • NCT04537936 · 285 participants · NA

    Psychotherapy Intervention for Latinos With Adv Cancer

  • NCT04965675 · 285 participants · Phase 3

    A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine

  • NCT05320835 · 285 participants · NA

    A Setting Focus Overdose Prevention Intervention

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02797600, the US trial registry maintained by the National Library of Medicine. NCT02797600 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.